Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.340 | 3.340 | 0.000 |
Stocks | 96.660 | 96.660 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 29.211 | 29.426 |
Price to Book | 7.952 | 6.950 |
Price to Sales | 5.319 | 5.001 |
Price to Cash Flow | 22.627 | 20.150 |
Dividend Yield | 0.941 | 0.661 |
5 Years Earnings Growth | 11.312 | 16.718 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 36.270 | 13.199 |
Technology | 22.750 | 37.671 |
Financial Services | 19.470 | 10.552 |
Consumer Cyclical | 8.600 | 14.396 |
Industrials | 8.470 | 7.503 |
Communication Services | 4.430 | 11.980 |
Number of long holdings: 23
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Mastercard | US57636Q1040 | 7.57 | 535.71 | +1.28% | |
Microsoft | US5949181045 | 7.04 | 439.33 | +0.94% | |
UnitedHealth | US91324P1021 | 6.50 | 506.10 | -0.05% | |
West Pharmaceutical Services | US9553061055 | 6.05 | 332.77 | +0.97% | |
Tyler Technologies | US9022521051 | 5.96 | 599.26 | +0.82% | |
IDEXX Labs | US45168D1046 | 5.93 | 413.62 | +0.11% | |
ADP | US0530151036 | 4.57 | 296.46 | +0.79% | |
Mettler-Toledo | US5926881054 | 4.54 | 1,246.30 | +0.96% | |
Accenture | IE00B4BNMY34 | 4.51 | 361.63 | +0.80% | |
Adobe | US00724F1012 | 4.48 | 447.94 | +0.27% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Seilern Stryx World Growth EUR U | 1.68B | 8.62 | 0.02 | 12.76 | ||
Seilern Stryx World Growth EUR H R | 1.68B | 4.43 | -3.68 | 9.77 | ||
IE00BF5H5052 | 1.68B | 1.14 | -4.59 | - | ||
IE00BD8DY654 | 311.52M | 2.57 | -3.26 | - | ||
IE00B68JD125 | 67.67M | 8.36 | 0.86 | 7.09 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review